The global diagnostics market was valued at approximately $180 billion in 2022 and is projected to grow to over $348 billion by 2030. Some of the key drivers of that growth are molecular diagnostics ...

A few weeks ago, when we revisited Eric Topol's top 10 digital health predictions, Topol mentioned microfluidics -- and the ability to create home versions of medical lab tests -- as one of the ...

San Diego, California-based Cue, not to be confused with fertility tracker company Clue, raised $7.5 million in a round led by SherpaVentures with participation from existing investor Immortalana.

Cue Health (HLTH) made a name for itself with a rapid at-home COVID-19 test, a machine with a $200 price tag, and is out with 13 new tests this week, though none is compatible with the new machine.

Two years after its cartridge-based diagnostic became the first COVID-19 test given emergency use authorization by the FDA for non-prescription, at-home use, Cue Health has now scored the agency’s ...

Beginning November 15th, Consumers Can Get Cue's Fast and Accurate COVID-19 Tests, 24/7 Virtual Care, E-Prescription Services, and CDC-Compliant Test Results for Travel: Anywhere, Anytime SAN DIEGO, ...

The U.S. Food and Drug Administration told consumers Monday to throw out any at-home COVID-19 tests made by San Diego biotech Cue Health, because they could give users false results. Early in the ...